Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADCs
Biotech
Alentis raises $181M series D to bring ADCs to the clinic
Swiss biotech Alentis Therapeutics has secured $181 million, money that will be used to launch clinical trials for two ADCs.
Gabrielle Masson
Nov 12, 2024 7:00am
BigHat, Synaffix collab outfits AI science with ADC tech
Nov 4, 2024 11:07am
Day One doles out $55M for MabCare’s solid tumor ADC
Jun 18, 2024 10:55am
ASCO: It's back to the basics for cancer drug developers
Jun 5, 2024 10:55am
AbbVie rebuilds ADC portfolio with hope of replacing chemotherapy
Jun 4, 2024 11:26am
Mersana's phase 1 ADC cancer trial breaks free of FDA hold
Oct 31, 2023 1:21pm
